27 December 2024
: Case report 
Metapneumovirus-Induced Myocarditis Complicated by Klebsiella pneumoniae Co-Infection: A Case Report
Rare coexistence of disease or pathology
Shih-Hung Wang
ABEF 1, Mei-Hui Lee ADF 2, Yuarn-Jang Lee CD 2, Yung-Ching Liu CDG 2*
DOI: 10.12659/AJCR.946119
Am J Case Rep 2024; 25:e946119
Table 2. Antibiotic susceptibility profile of Klebsiella pneumoniae isolated from sputum culture; minimum inhibitory concentration (MIC).
| Culture name | Result (MIC) |
|---|---|
| Isolated | |
| Ampicillin | R(16) |
| Cefazolin | S(≤2) |
| Gentamicin | S(≤2) |
| Amikacin | S(≤8) |
| Cefmetazole | S(≤8) |
| Ceftazidime | S(≤1) |
| Imipenem | S(≤0.25) |
| Cefotaxime | S(≤1) |
| Ceftriaxone | S(≤1) |
| Cefepime | S(≤1) |
| Ciprofloxacin | S(≤0.5) |
| Levofloxacin | S(≤1) |
| Meropenem | S(≤0.25) |
| Ampicillin/Sulbactam | S(≤4) |
| Trimethoprim/Sulfamethoxazole | S(≤0.5) |
| Piperacillin/Tazobactam | S(≤4) |
| Tigecycline | S(1) |
| Ertapenem | S(≤0.25) |
| Minocycline | S(2) |